0001179110-21-008690.txt : 20210909
0001179110-21-008690.hdr.sgml : 20210909
20210909170738
ACCESSION NUMBER: 0001179110-21-008690
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210907
FILED AS OF DATE: 20210909
DATE AS OF CHANGE: 20210909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Veness Adam M
CENTRAL INDEX KEY: 0001778623
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36065
FILM NUMBER: 211245105
MAIL ADDRESS:
STREET 1: C/O ACCELERON PHARMA INC.
STREET 2: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACCELERON PHARMA INC
CENTRAL INDEX KEY: 0001280600
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-649-9200
MAIL ADDRESS:
STREET 1: 128 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2021-09-07
0
0001280600
ACCELERON PHARMA INC
XLRN
0001778623
Veness Adam M
128 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
SVP, General Counsel and Sec.
Common Stock
2021-09-07
4
F
0
587
129.36
D
20336
D
Common Stock
2021-09-08
4
S
0
6
130.00
D
20330
D
Common Stock
2021-09-09
4
S
0
1407
130.00
D
18923
D
The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
/s/ Adam M. Veness
2021-09-09